Selvadurai, Louisa P.
Perlman, Susan L.
Ashizawa, Tetsuo
Wilmot, George R.
Onyike, Chiadi U.
Rosenthal, Liana S.
Shakkottai, Vikram G.
Paulson, Henry L.
Subramony, Sub H.
Bushara, Khalaf O.
Kuo, Sheng-Han
Dietiker, Cameron
Geschwind, Michael D.
Nelson, Alexandra B.
Gomez, Christopher M.
Opal, Puneet
Zesiewicz, Theresa A.
Hawkins, Trevor
Yacoubian, Talene A.
Nopoulos, Peggy C.
Sha, Sharon J.
Morrison, Peter E.
Figueroa, Karla P.
Pulst, Stefan M.
Schmahmann, Jeremy D.
Article History
Accepted: 14 December 2023
First Online: 2 January 2024
Declarations
:
: Approval was obtained for study procedures at all sites via the local IRB at each institution, and all participants gave informed consent. The central sites (UCLA for CRC-SCA and Houston Methodist for READISCA) prepared the original IRB documents that were used by all participating sites during their local reviews.
: L.P.S. was funded by an Australian-American Fulbright Commission scholarship.C.U.O. receives research support from Alector Inc. and Transposon Inc., and consults for Acadia Pharmaceuticals. He is also supported by the Robert and Nancy Hall for Brain Research, and the Joseph Trovato Fund.L.S.R. is site PI for Biohaven Pharma and has consulted for Bial Biotech and Reata Pharmaceuticals. She receives research support from NINDS, Pfizer, the National Ataxia Foundation, Gordon and Marilyn Macklin Foundation, and the Daniel B and Florence E. Green Foundation.M.D.G is site PI for Biohaven Pharma, receives funding from the NIH/NIA (R01 AG AG031189; R01AG062562; R56 AG055619) and is supported by the Michael J. Homer Family Fund.J.D.S. is site PI for Biohaven Pharma, consults for Biohaven, and holds the copyright with the General Hospital Corporation to the Brief Ataxia Rating scale, Patient Reported outcome Measure of Ataxia, the Cerebellar Cognitive Affective / Schmahmann Syndrome Scale, and the Cerebellar Neuropsychiatric Rating Scale.